Grupos de investigación Todos los grupos >>

Servicio de Hemoterapia y Hemostasia

HEMATO-IDIBAPS

Servicio de Hemoterapia y Hemostasia

Hospital Clínic - Institut d’Investigacions Biomèdiques August Pi i Sunyer. Barcelona

  • Lopez-Vilchez I, Diaz-Ricart M, Galán AM, Roqué M, Caballo C, Molina P, White JG, Escolar G Internalization of Tissue Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly. J. Cell. Biochem. 2016; 117: 448-57

    Ver abstract

  • Fernández-Ruiz R, Pino M, Hurtado B, García de Frutos P, Caballo C, Escolar G, Gomis R, Diaz-Ricart M Role of sodium tungstate as a potential antiplatelet agent. Drug Des Devel Ther 2015; 9: 2777-86

    Ver abstract

  • Barón Esquivias G, Escolar Albaladejo G, Zamorano JL, Betegón Nicolás L, Canal Fontcuberta C, de Salas-Cansado M, Rubio-Rodríguez D, Rubio-Terrés C Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain. Rev Esp Cardiol (Engl Ed) 2015; 68: 680-90

    Ver abstract

  • Arellano-Rodrigo E, Lopez-Vilchez I, Galán AM, Molina P, Reverter JC, Carne X, Villalta J, Tàssies D, Lozano M, Diaz-Ricart M, Escolar G Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers. Transfus Med Rev 2015; 29: 242-9

    Ver abstract

  • Martin-Rodriguez S, Caballo C, Gutiérrez G, Vera M, Cruzado JM, Cases A, Escolar G, Diaz-Ricart M TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. Eur. J. Clin. Invest. 2015; 45: 160-9

    Ver abstract

  • Cid J, Lozano M, Ziman A, West KA, O'Brien KL, Murphy MF, Wendel S, Vázquez A, Ortín X, Hervig TA, Delaney M, Flegel WA, Yazer MH Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. Br. J. Haematol. 2015; 168: 598-603

    Ver abstract

  • Cid J, Magnano L, Acosta M, Alba C, Esteve J, Lozano M Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness. Platelets 2015; 26: 190-4

    Ver abstract

  • Cuadrado-Godia E, Regueiro A, Núñez J, Díaz-Ricard M, Novella S, Oliveras A, Valverde MA, Marrugat J, Ois A, Giralt-Steinhauer E, Sanchis J, Escolar G, Hermenegildo C, Heras M, Roquer J Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy. PLoS ONE 2015; 10: e0132415

    Ver abstract

  • Escolar G, Carne X, Arellano-Rodrigo E Dosing of rivaroxaban by indication: getting the right dose for the patient. Expert Opin Drug Metab Toxicol 2015; 11: 1665-77

    Ver abstract

  • Escolar G, Arellano-Rodrigo E, Lopez-Vilchez I, Molina P, Sanchis J, Reverter JC, Carne X, Cid J, Villalta J, Tàssies D, Galán AM, Diaz-Ricart M Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human blood. Circ. J. 2015; 79: 331-8

    Ver abstract

  • Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N, Haneline LS, Robertson KA, Skiles J, Diaz-Ricart M, Carreras E, Renbarger J, Hanash S, Bies RR, Paczesny S Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant. 2015; 21: 1739-45

    Ver abstract

  • Martin-Rodriguez S, Reverter JC, Tàssies D, Espinosa G, Heras M, Pino M, Escolar G, Diaz-Ricart M Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus. Lupus 2015; 24: 1143-9

    Ver abstract

  • Regueiro A, Cuadrado-Godia E, Bueno-Betí C, Diaz-Ricart M, Oliveras A, Novella S, Gené GG, Jung C, Subirana I, Ortiz-Pérez JT, Roqué M, Freixa X, Núñez J, Escolar G, Marrugat J, Hermenegildo C, Valverde MA, Roquer J, Sanchis J, Heras M Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke. J. Mol. Cell. Cardiol. 2015; 80: 146-55

    Ver abstract

  • Regueiro A, Freixa X, Fernández-Rodríguez D, Diaz-Ricart M, Escolar G, Martín-Yuste V, Brugaletta S, Sabaté M, Masotti M Platelet reactivity assessment with VerifyNow®: substitute or complement for light transmission aggregometry? Int. J. Cardiol. 2015; 178: 221-2

    Ver abstract

  • Ill-Raga G, Palomer E, Ramos-Fernández E, Guix FX, Bosch-Morató M, Guivernau B, Tajes M, Valls-Comamala V, Jiménez-Conde J, Ois A, Pérez-Asensio F, Reyes-Navarro M, Caballo C, Gil-Gómez G, Lopez-Vilchez I, Galán AM, Alameda F, Escolar G, Opazo C, Planas A, Planas AM, Roquer J, Valverde MA, Muñoz FJ Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death. Biochim. Biophys. Acta 2015; 1852: 421-8

    Ver abstract

  • Aibar J, Castro P, Espinosa G, Fernández S, Hernández C, Rinaudo M, Butjosa M, Tàssies D, Reverter JC, Nicolás JM ADAMTS-13 in Critically Ill Patients With Septic Syndromes and Noninfectious Systemic Inflammatory Response Syndrome. Shock 2015; 43: 556-62

    Ver abstract

  • Cid J, Molina JM, Mustieles MJ, Periáñez M, Lozano M Comparison of plasma exchange procedures using three apheresis systems. Transfusion 2015; 55: 1001-7

    Ver abstract

  • Cid J, Lozano M, Klein HG, Flegel WA Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes. Blood Transfus 2014; 12: 301-6

    Ver abstract

  • Cid J Iron chelation for iron overload secondary to transfusions of packed red blood cells. Clin Adv Hematol Oncol 2014; 12: 184-5

    Ver abstract

  • Cid J, Magnano L, Lozano M Automation of blood component preparation from whole blood collections. Vox Sang. 2014; 107: 10-8

    Ver abstract

  • Diaz-Ricart M, Escolar G Vorapaxar for the reduction of atherothrombotic events. Drugs Today 2014; 50: 747-56

    Ver abstract

  • Batlle M, Recarte-Pelz P, Roig E, Castel MA, Cardona M, Farrero M, Ortiz JT, Campos B, Pulgarín MJ, Ramírez J, Pérez-Villa F, García de Frutos P AXL receptor tyrosine kinase is increased in patients with heart failure. Int. J. Cardiol. 2014; 173: 402-9

    Ver abstract

  • Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Smits PC, Kaiser C, D'Ascenzo F, Frati G, Mancone M, Généreux P, Stone GW Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J. Am. Coll. Cardiol. 2014; 63: 299-307

    Ver abstract

  • Mejía JC, Espinosa G, Tàssies D, Reverter JC, Cervera R Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy. Clin. Exp. Rheumatol. 2014; 32: S67-71

    Ver abstract

  • Cases A, Portolés J, Calls J, Martínez-Castelao A, Munar MA, Segarra A Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study. Int Urol Nephrol 2014; 46: 1983-95

    Ver abstract

  • Wildhagen KC, García de Frutos P, Reutelingsperger CP, Schrijver R, Aresté C, Ortega-Gómez A, Deckers NM, Hemker HC, Soehnlein O, Nicolaes GA Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood 2014; 123: 1098-101

    Ver abstract

  • García de Frutos P A novel method to detect causative mutations in fibrinogen, using a small amount of blood processed through HPLC and time of flight (TOF) mass spectrometry. Thromb. Haemost. 2014; 111: 565-6

    Ver abstract

  • Tàssies D, García de Frutos P Protein S deficiency and novel oral anticoagulants: an intriguing case. Thromb. Res. 2014; 134: 1-2

    Ver abstract

  • Cid J, Carbassé G, Andreu B, Baltanás A, Garcia-Carulla A, Lozano M Efficacy and safety of plasma exchange: ann 11-year single-center experience of 2730 procedures in 317 patients. Transfus. Apher. Sci. 2014; 51: 209-14

    Ver abstract

  • Lozano M, Mahon A, van der Meer PF, Stanworth S, Cid J, Devine D, Fung MK, de la Salle B, Heddle NM Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative - UK NEQAS(H) International Exercise. Vox Sang. 2014; 106: 330-6

    Ver abstract

  • Cid J, Magnano L, Molina P, Diaz-Ricart M, Martínez N, Maymó RM, Puig L, Lozano M, Escolar G, Galán AM Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days. Transfusion 2014; 54: 426-33

    Ver abstract

  • Escolar G, Diaz-Ricart M, Arellano-Rodrigo E, Galán AM The pharmacokinetics of edoxaban for the prevention and treatment of venous thromboembolism. Expert Opin Drug Metab Toxicol 2014; 10: 445-58

    Ver abstract

  • Cid J, Palomera L, Díaz M, Zamora C, Solano F Clinical characteristics and management of iron overload in 631 patients with chronic transfusion dependency: results from a multicentre, observational study. Blood Transfus 2014; 12 Suppl 1: s119-23

    Ver abstract

  • Lopez-Vilchez I, Serra-Millàs M, Navarro V, Rosa Hernandez M, Villalta J, Diaz-Ricart M, Gasto C, Escolar G, Galán AM Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment. J Affect Disord 2014; 159: 39-45

    Ver abstract

  • Guardiola C, Gómez F, Fleta C, Rodríguez J, Quirion D, Pellegrini G, Lousa A, Martínez-de-Olcoz L, Pombar M, Lozano M Neutron measurements with ultra-thin 3D silicon sensors in a radiotherapy treatment room using a Siemens PRIMUS linac. Phys Med Biol 2013; 58: 3227-42

    Ver abstract

  • Tajes M, Ill-Raga G, Palomer E, Ramos-Fernández E, Guix FX, Bosch-Morató M, Guivernau B, Jiménez-Conde J, Ois A, Pérez-Asensio F, Reyes-Navarro M, Caballo C, Galán AM, Alameda F, Escolar G, Opazo C, Planas A, Roquer J, Valverde MA, Muñoz FJ Nitro-oxidative stress after neuronal ischemia induces protein nitrotyrosination and cell death. Oxid Med Cell Longev 2013; 2013: 826143

    Ver abstract

  • Berman H, Ugarte-Gil MF, Espinosa G, Tàssies D, Monteagudo J, Reverter JC, Cervera R Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome? Clin. Exp. Rheumatol. 2013; 31: 926-32

    Ver abstract

  • Lozano M, Cid J Analysis of reasons for not implementing pathogen inactivation for platelet concentrates. Transfus Clin Biol 2013; 20: 158-64

    Ver abstract

  • Rovira J, Cid J, Gutiérrez-García G, Pereira A, Fernández-Avilés F, Rosiñol L, Martínez C, Carreras E, Urbano A, Rovira M, Lozano M Fatal immune hemolytic anemia following allogeneic stem cell transplantation: report of 2 cases and review of literature. Transfus Med Rev 2013; 27: 166-70

    Ver abstract

  • Lozano M, Cid J, Areal C, Romon I, Muncunill J Apheresis activity in Spain: a survey of the Spanish Apheresis Group. Transfus. Apher. Sci. 2013; 49: 560-4

    Ver abstract

  • Fontseré N, Mestres G, Barrufet M, Burrel M, Vera M, Arias M, Massó E, Cases A, Maduell F, Campistol JM Practical utility of thermodilution versus doppler ultrasound to measure hemodialysis blood access flow. Nefrologia 2013; 33: 325-32

    Ver abstract

  • Lozano M, Cid J Pathogen inactivation: coming of age. Curr. Opin. Hematol. 2013; 20: 540-5

    Ver abstract

  • Lozano M, Cid J, Müller TH Plasma treated with methylene blue and light: clinical efficacy and safety profile. Transfus Med Rev 2013; 27: 235-40

    Ver abstract

  • Carmona A, Diaz-Ricart M, Palomo M, Molina P, Pino M, Rovira M, Escolar G, Carreras E Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. Biol. Blood Marrow Transplant. 2013; 19: 1439-45

    Ver abstract

  • Dzik WH, Beckman N, Murphy MF, Delaney M, Flanagan P, Fung M, Germain M, Haspel RL, Lozano M, Sacher R, Szczepiorkowski Z, Wendel S Factors affecting red blood cell storage age at the time of transfusion. Transfusion 2013; 53: 3110-9

    Ver abstract

  • Gómez-Puerta JA, Peris P, Reverter JC, Espinosa G, Martinez-Ferrer A, Monegal A, Monteagudo J, Tàssies D, Guañabens N High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature. Medicine (Baltimore) 2013; 92: 295-304

    Ver abstract

  • Maduell F, Arias M, Massó E, Fontseré N, Carrera M, Vera M, Cases A, Campistol JM Sensitivity of blood volume monitoring for fluid status assessment in hemodialysis patients. Blood Purif. 2013; 35: 202-8

    Ver abstract

  • Recarte-Pelz P, Tàssies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC, de Frutos PG Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res. Ther. 2013; 15: R41

    Ver abstract

  • Blasi A, Caballo C, Galán AM, Taura P, Beltrán J, Escolar G, Lozano M The addition of MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine. Clin. Chem. Lab. Med. 2013; 51: e297-9

    Ver abstract

  • Merino A, Cid J Very unusual presentation of pernicious anemia with schistocytes in peripheral blood. Blood 2013; 122: 3862

    Ver abstract

  • González-Juanatey JR, Lobos JM, Reverter JC, Becerra V Self-management of Vitamin K Antagonists Is More Cost-effective Than Dabigatran for Stroke Prevention in Non-valvular Atrial Fibrillation in Spain. Response. Rev Esp Cardiol (Engl Ed) 2013; 66: 511

    Ver abstract

  • Pujadas-Mestres L, Escolar G, Arellano-Rodrigo E, Galán AM Apixaban in the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation. Drugs Today 2013; 49: 425-36

    Ver abstract

  • Saibeni S, Etchevers MJ, Tàssies D, Panés J, Reverter JC, Danese S, Piqué JM, Bruno S, Vecchi M, Gasbarrini A, Sans M Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases. Int J Colorectal Dis 2013; 28: 1281-6

    Ver abstract

  • Grande M, Ordoñez E, Cirigliano V, Cid J, Grau E, Pericot A, Teixido I, Marín JL, Borrell A Clinical application of midtrimester non-invasive fetal RHD genotyping and identification of RHD variants in a mixed-ethnic population. Prenat. Diagn. 2013; 33: 173-8

    Ver abstract

  • Cid J, Harm SK, Yazer MH Platelet transfusion - the art and science of compromise. Transfus Med Hemother 2013; 40: 160-71

    Ver abstract

  • Olivar R, Luque A, Naranjo-Gómez M, Quer J, García de Frutos P, Borràs FE, Rodríguez de Córdoba S, Blom AM, Aran JM The α7β0 isoform of the complement regulator C4b-binding protein induces a semimature, anti-inflammatory state in dendritic cells. J. Immunol. 2013; 190: 2857-72

    Ver abstract

  • Comas J, Arcos E, Castell C, Cases A, Martínez-Castelao A, Doñate T, Esmatjes E Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia. Nephrol. Dial. Transplant. 2013; 28: 1191-8

    Ver abstract

  • Caballo C, Escolar G, Diaz-Ricart M, Lopez-Vilchez I, Lozano M, Cid J, Pino M, Beltrán J, Basora M, Pereira A, Galán AM Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates. Blood Transfus 2013; 11: 391-9

    Ver abstract

  • Cid J, Caballo C, Pino M, Galán AM, Martínez N, Escolar G, Diaz-Ricart M Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light. Transfusion 2013; 53: 600-5

    Ver abstract

  • Cid J, Elena M, Diekmann F, Lozano M Haptoglobin is present in albumin used as a replacement solution for plasma exchange. Transfusion 2013; 53: 757-60

    Ver abstract

  • Escolar G, Fernandez-Gallego V, Arellano-Rodrigo E, Roquer J, Reverter JC, Sanz VV, Molina P, Lopez-Vilchez I, Diaz-Ricart M, Galán AM Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human blood. PLoS ONE 2013; 8: e78696

    Ver abstract

  • Pérez-Pujol S, Aras O, Escolar G Factor v leiden and inflammation. Thrombosis 2012; 2012: 594986

    Ver abstract

  • Maduell F, Rodriguez N, Arias-Guillén M, Jiménez S, Alemany B, Durán C, Fontseré N, Vera M, Carrera M, Arcal C, Pérez N, Cases A, Campistol JM Dialysate calcium individualisation: a pending issue. Nefrologia 2012; 32: 579-86

    Ver abstract

  • Maduell F, Arias M, Durán CE, Vera M, Fontseré N, Azqueta M, Rico N, Pérez N, Sentis A, Elena M, Rodriguez N, Arcal C, Bergadá E, Cases A, Bedini JL, Campistol JM Nocturnal, every-other-day, online haemodiafiltration: an effective therapeutic alternative. Nephrol. Dial. Transplant. 2012; 27: 1619-31

    Ver abstract

  • Martínez-Zamora MA, Peralta S, Creus M, Tàssies D, Reverter JC, Espinosa G, Cervera R, Carmona F, Balasch J Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study. Ann. Rheum. Dis. 2012; 71: 61-6

    Ver abstract

  • Pérez A, Franch J, Cases A, González Juanatey JR, Conthe P, Gimeno E, Matali A [Relationship between the degree of glycemic control and diabetes characteristics and hyperglycemia treatment in type 2 diabetes. DIABES Study]. Med Clin (Barc) 2012; 138: 505-11

    Ver abstract

  • Torregrosa JV, Durán CE, Barros X, Blasco M, Arias M, Cases A, Campistol JM Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. Nefrologia 2012; 32: 329-34

    Ver abstract

  • Raffa S, Reverter JC, Seijo S, Tàssies D, Abraldes JG, Bosch J, García-Pagán JC Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis. Clin. Gastroenterol. Hepatol. 2012; 10: 72-8

    Ver abstract

  • Losonczy G, Vajas A, Takács L, Dzsudzsák E, Fekete A, Márhoffer E, Kardos L, Ajzner E, Hurtado B, de Frutos PG, Berta A, Balogh I Effect of the Gas6 c.834+7G>A polymorphism and the interaction of known risk factors on AMD pathogenesis in Hungarian patients. PLoS ONE 2012; 7: e50181

    Ver abstract

  • Hernández MR, Urban P, Casals E, Estelrich J, Escolar G, Galán AM Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity. Int J Nanomedicine 2012; 7: 2339-47

    Ver abstract

  • Caballo C, Palomo M, Cases A, Galán AM, Molina P, Vera M, Bosch X, Escolar G, Diaz-Ricart M NFκB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS ONE 2012; 7: e43374

    Ver abstract

  • Ballesteros F, Tàssies D, Reverter JC, Alobid I, Bernal-Sprekelsen M Idiopathic sudden sensorineural hearing loss: classic cardiovascular and new genetic risk factors. Audiol. Neurootol. 2012; 17: 400-8

    Ver abstract

  • Cid J, Escolar G, Lozano M Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials. Vox Sang. 2012; 103: 322-30

    Ver abstract

  • Diekmann F, Rovira J, Diaz-Ricart M, Arellano EM, Vodenik B, Jou JM, Vives-Corrons JL, Escolar G, Campistol JM mTOR inhibition and erythropoiesis: microcytosis or anaemia? Nephrol. Dial. Transplant. 2012; 27: 537-41

    Ver abstract

  • Gely-Pernot A, Coronas V, Harnois T, Prestoz L, Mandairon N, Didier A, Berjeaud JM, Monvoisin A, Bourmeyster N, de Frutos PG, Philippe M, Benzakour O An endogenous vitamin K-dependent mechanism regulates cell proliferation in the brain subventricular stem cell niche. Stem Cells 2012; 30: 719-31

    Ver abstract

  • García de Frutos P Protein S: an anticoagulant in its own right. Thromb. Haemost. 2012; 107: 601

    Ver abstract

  • Reverter JL, Tàssies D, Alonso N, Pellitero S, Sanmartí A, Reverter JC Non-detectable Chlamydophila pneumoniae DNA in peripheral leukocytes in type 2 diabetes mellitus patients with and without carotid atherosclerosis. Med Clin (Barc) 2012; 138: 11-4

    Ver abstract

  • Lopez-Vilchez I, Galán AM, Hernández MR, Caballo C, Roqué M, Diaz-Ricart M, White JG, Escolar G Platelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro. Thromb. Res. 2012; 130: e294-300

    Ver abstract

  • Font C, Farrús B, Vidal L, Caralt TM, Visa L, Mellado B, Tàssies D, Monteagudo J, Reverter JC, Gascon P Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients. Ann. Oncol. 2011; 22: 2101-6

    Ver abstract

  • Galán AM, Lozano M, Molina P, Navalon F, Marschner S, Goodrich R, Escolar G Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function. Transfusion 2011; 51: 808-15

    Ver abstract

  • Palomo M, Diaz-Ricart M, Rovira M, Escolar G, Carreras E Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 2011; 17: 497-506

    Ver abstract

  • Hurtado B, Muñoz X, Recarte-Pelz P, García N, Luque A, Krupinski J, Sala N, García de Frutos P Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques. Thromb. Haemost. 2011; 105: 873-82

    Ver abstract

  • Pinazo MJ, Tàssies D, Muñoz J, Fisa R, Posada Ede J, Monteagudo J, Ayala E, Gallego M, Reverter JC, Gascon J Hypercoagulability biomarkers in Trypanosoma cruzi -infected patients. Thromb. Haemost. 2011; 106: 617-23

    Ver abstract

  • Lopez-Vilchez I, Hedner U, Altisent C, Diaz-Ricart M, Escolar G, Galán AM Redistribution and hemostatic action of recombinant activated factor VII associated with platelets. Am. J. Pathol. 2011; 178: 2938-48

    Ver abstract

  • Serra-Millàs M, Lopez-Vilchez I, Navarro V, Galán AM, Escolar G, Penadés R, Catalán R, Fañanás L, Arias B, Gasto C Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression. Psychopharmacology (Berl.) 2011; 216: 1-8

    Ver abstract

  • Font C, Vidal L, Espinosa G, Tàssies D, Monteagudo J, Farrús B, Visa L, Cervera R, Gascon P, Reverter JC Solid cancer, antiphospholipid antibodies, and venous thromboembolism. Autoimmun Rev 2011; 10: 222-7

    Ver abstract

  • Freixa X, Masotti M, Palomo M, Diaz-Ricart M, Escolar G, Guasch E, Regueiro A, Jiménez M, Betriu A, Heras M Endothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarction. Microvasc. Res. 2011; 82: 177-81

    Ver abstract

  • Roqué M, Sitges M, Sala J, Delgado V, Morales M, Marrugat J, Vila J, Subirana I, Tàssies D, Reverter JC, Castro M, Duran M [Effects of raloxifene on endothelial function and hemostasis in women with ischemic heart disease]. Rev Esp Cardiol 2011; 64: 572-8

    Ver abstract

  • Hanzu FA, Palomo M, Kalko SG, Parrizas M, Garaulet M, Escolar G, Gomis R, Diaz-Ricart M Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses. J. Thromb. Haemost. 2011; 9: 1236-45

    Ver abstract

  • Martínez-Zamora MA, Creus M, Tàssies D, Reverter JC, Civico S, Carmona F, Balasch J Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer. Hum. Reprod. 2011; 26: 510-6

    Ver abstract

  • Cid J, Carbassé G, Pereira A, Sanz C, Mazzara R, Escolar G, Lozano M Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients. Transfusion 2011; 51: 1163-9

    Ver abstract

  • Guasch E, Sionis A, Reverter JC, Andrea R, Loma-Osorio P, Freixa X, Heras M Safety issues of adjunctive clopidogrel in patients discharged after percutaneous coronary intervention with stent placement and requiring oral anticoagulation. Int. J. Cardiol. 2011; 146: e1-4

    Ver abstract

  • Gómez-Gil E, Navinés R, Martínez De Osaba MJ, Diaz-Ricart M, Escolar G, Salamero M, Martín-Santos R, Galán A, Gasto C Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment. Psychoneuroendocrinology 2010; 35: 481-9

    Ver abstract

  • Palomo M, Diaz-Ricart M, Carbó C, Rovira M, Fernández-Avilés F, Martine C, Ghita G, Escolar G, Carreras E Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biol. Blood Marrow Transplant. 2010; 16: 985-93

    Ver abstract

  • Brunso L, Segura D, Monreal L, Escolar G, White JG, Diaz-Ricart M The secretory mechanisms in equine platelets are independent of cytoskeletal polymerization and occur through membrane fusion. Platelets 2010; 21: 658-66

    Ver abstract

  • Maduell F, Arias M, Fontseré N, Vera M, Massó E, Garro J, Barros X, Martina MN, Elena M, Bergadá E, Cases A, Bedini JL, Campistol JM What infusion flow should be used for mid-dilution hemodiafiltration? Blood Purif. 2010; 30: 25-33

    Ver abstract

  • Cid J, Escolar G, Lozano M Prophylactic platelet transfusions. N. Engl. J. Med. 2010; 362: 2140; author reply 2141-2

    Ver abstract

  • Llacuna L, Bárcena C, Bellido-Martín L, Fernández L, Stefanovic M, Marí M, García-Ruiz C, Fernández-Checa JC, García de Frutos P, Morales A Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury. Hepatology 2010; 52: 1371-9

    Ver abstract

  • Fort J, Cuevas X, García F, Pérez-García R, Lladós F, Lozano J, Martín-Malo A Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study. Nephrol. Dial. Transplant. 2010; 25: 2702-10

    Ver abstract

  • Collado S, Coll E, Deulofeu R, Guerrero L, Pons M, Cruzado JM, de la Torre B, Vera M, Azqueta M, Nicolau C, Cases A [Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors]. Nefrologia 2010; 30: 342-8

    Ver abstract

  • Maduell F, Arias M, Garro J, Vera M, Fontseré M, Barros X, Massó E, Martina MN, Sentis A, Durán C, Bergadá E, Cases A, Campistol JM [Guidelines for automated manual infusion: a practical way of prescribing postdilution on-line hemodiafiltration]. Nefrologia 2010; 30: 349-53

    Ver abstract

  • Martínez-Zamora MA, Tàssies D, Carmona F, Espinosa G, Cervera R, Reverter JC, Balasch J Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies. J. Reprod. Immunol. 2010; 86: 133-40

    Ver abstract

  • Hurtado B, Abasolo N, Muñoz X, García N, Benavente Y, Rubio F, García de Frutos P, Krupinski J, Sala N Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis. Thromb. Haemost. 2010; 104: 592-8

    Ver abstract

  • Pellitero S, Reverter JL, Tàssies D, Pizarro E, Monteagudo J, Salinas I, Aguilera E, Sanmartí A, Reverter JC Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes. Thromb. Haemost. 2010; 103: 630-7

    Ver abstract

  • Diaz-Ricart M, Brunso L, Pino M, Navalon F, Jou JM, Heras M, White JG, Escolar G Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters. Thromb. Res. 2010; 126: e30-5

    Ver abstract

  • Larrea CF, Cofan F, Oppenheimer F, Campistol JM, Escolar G, Lozano M Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation. Transplantation 2010; 89: 903-4

    Ver abstract

  • Lopez-Vilchez I, Escolar G, Galán AM Traffic of rFVIIa through Endothelial Cells and Redistribution into Subendothelium: Implications for a Prolonged Hemostatic Effect Journal of Coagulation Disorders 2009; 1: 1-6

    Ver abstract

  • Lopez-Vilchez I, Tonda R, Hernandez RM, Navalon F, Diaz-Ricart M, Galán AM, Escolar G Relative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in-vitro studies with circulating blood. Coron. Artery Dis. 2009; 20: 392-9

    Ver abstract

  • Hernández MR, Fusté B, Cases A, Tonda R, Escolar G, Ordinas A, Diaz-Ricart M Haemodialysis through a cellulose membrane induces dephosphorylation of CD11b and promotes leukocyte adhesion to endothelial cells. Clin Invest Med 2009; 32: E48-56

    Ver abstract

  • de la Red G, Tàssies D, Espinosa G, Monteagudo J, Bové A, Plaza J, Cervera R, Reverter JC Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels. Thromb. Haemost. 2009; 101: 312-6

    Ver abstract

  • Pellitero S, Reverter JL, Granada ML, Pizarro E, Pastor MC, Tàssies D, Reverter JC, Salinas I, Sanmartí A Association of the IGF1/pregnancy-associated plasma protein-A system and adipocytokine levels with the presence and the morphology of carotid plaques in type 2 diabetes mellitus patients with stable glycaemic control. Eur. J. Endocrinol. 2009; 160: 925-32

    Ver abstract

  • Galán AM, Lopez-Vilchez I, Diaz-Ricart M, Navalon F, Gomez E, Gasto C, Escolar G Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thromb. Haemost. 2009; 102: 511-9

    Ver abstract

  • Arellano-Rodrigo E, Alvarez-Larrán A, Reverter JC, Colomer D, Villamor N, Bellosillo B, Cervantes F Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. Am. J. Hematol. 2009; 84: 102-8

    Ver abstract

  • Ballesteros F, Alobid I, Tàssies D, Reverter JC, Scharf RE, Guilemany JM, Bernal-Sprekelsen M Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors? Audiol. Neurootol. 2009; 14: 139-45

    Ver abstract

  • Palomo M, Diaz-Ricart M, Carbó C, Rovira M, Fernández-Avilés F, Escolar G, Eissner G, Holler E, Carreras E The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. Biol. Blood Marrow Transplant. 2009; 15: 537-46

    Ver abstract

  • Tàssies D, Roqué M, Monteagudo J, Martorell T, Sionis A, Arzamendi D, Heras M, Reverter JC Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome. Thromb. Res. 2009; 124: 614-8

    Ver abstract

  • Lopez-Vilchez I, Diaz-Ricart M, White JG, Escolar G, Galán AM Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. Cardiovasc. Res. 2009; 84: 309-16

    Ver abstract

  • Trullàs JC, Barril G, Cofan F, Moreno A, Cases A, Fernandez-Lucas M, Martinez-Ara J, Ceballos M, Garcia-de-Diego J, Muñiz ML, Molina J, Martínez-Castelao A, González-Garcia J, Miró JM Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. AIDS Res. Hum. Retroviruses 2008; 24: 1229-35

    Ver abstract

  • Escolar G, Lopez-Vilchez I, Diaz-Ricart M, White JG, Galán AM Internalization of tissue factor by platelets. Thromb. Res. 2008; 122 Suppl 1: S37-41

    Ver abstract

  • Diaz-Ricart M, Palomo M, Fusté B, Lopez-Vilchez I, Carbó C, Pérez-Pujol S, White JG, Escolar G Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen. Thromb. Res. 2008; 121: 873-83

    Ver abstract

  • Maduell F, Vera M, Arias M, Fontseré N, Blasco M, Serra N, Bergadá E, Cases A, Campistol JM [How much should dialysis time be increased when catheters are used?]. Nefrologia 2008; 28: 633-6

    Ver abstract

  • Arderiu G, Pérez-Pujol S, Escolar G, White JG, Diaz-Ricart M External calcium facilitates signalling, contractile and secretory mechanisms induced after activation of platelets by collagen. Platelets 2008; 19: 172-81

    Ver abstract

  • Carbó C, Arderiu G, Escolar G, Fusté B, Cases A, Carrascal M, Abián J, Diaz-Ricart M Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum. Am. J. Kidney Dis. 2008; 51: 603-12

    Ver abstract

  • Díaz M, Sevilla P, Galán AM, Escolar G, Engel E, Gil FJ Evaluation of ion release, cytotoxicity, and platelet adhesion of electrochemical anodized 316 L stainless steel cardiovascular stents. J. Biomed. Mater. Res. Part B Appl. Biomater. 2008; 87: 555-61

    Ver abstract

  • Canaud B, Mingardi G, Braun J, Aljama P, Kerr PG, Locatelli F, Villa G, Van Vlem B, McMahon AW, Kerloëguen C, Beyer U Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Nephrol. Dial. Transplant. 2008; 23: 3654-61

    Ver abstract

  • Jiménez S, Tàssies D, Espinosa G, García-Criado A, Plaza J, Monteagudo J, Cervera R, Reverter JC Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus. Ann. Rheum. Dis. 2008; 67: 835-40

    Ver abstract

  • Tonda R, Lopez-Vilchez I, Navalon F, Pino M, Hernández MR, Escolar G, Galán AM Platelets interact with tissue factor immobilized on surfaces: effects of shear rate. Eur. J. Clin. Invest. 2008; 38: 34-42

    Ver abstract

  • Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Nefrologia 2008; 28 Suppl 3: 39-48

    Ver abstract

  • Coll E, Larrousse M, de la Sierra A, Collado S, Jimenez W, Cases A Chronic hypotension in hemodialysis patients: role of functional vascular changes and vasodilator agents. Clin. Nephrol. 2008; 69: 114-20

    Ver abstract

  • Alvarez-Larrán A, Arellano-Rodrigo E, Reverter JC, Domingo A, Villamor N, Colomer D, Cervantes F Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis. Ann. Hematol. 2008; 87: 269-76

    Ver abstract

  • Gutiérrez G, Merino A, Domingo A, Jou JM, Reverter JC EQAS for peripheral blood morphology in Spain: a 6-year experience. Int J Lab Hematol 2008; 30: 460-6

    Ver abstract

  • Maduell F, Serra N, Arias M, Vera M, Bergadá E, Cases A [Control of hypertension refractory to medical management by means of short daily hemodialysis]. Nefrologia 2008; 28: 99-101

    Ver abstract

  • Maduell F, Vera M, Arias M, Serra N, Blasco M, Bergadá E, Fontseré N, Cases A, Campistol JM Influence of the ionic dialysance monitor on Kt measurement in hemodialysis. Am. J. Kidney Dis. 2008; 52: 85-92

    Ver abstract

  • Navarro-Núñez L, Lozano ML, Palomo M, Martínez C, Vicente V, Castillo J, Benavente-García O, Diaz-Ricart M, Escolar G, Rivera J Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway. J. Agric. Food Chem. 2008; 56: 2970-6

    Ver abstract

  • Portolés JM, de Francisco AL, Górriz JL, Martínez-Castelao A, López-Gómez JM, Arias M, de la Cruz JJ, Cases A, Fernández E, Aljama P Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study. Kidney Int. Suppl. 2008; : S82-7

    Ver abstract

  • Sambola A, Heras M, Escolar G, Lozano M, Pino M, Martorell T, Torra M, Sanz G The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin. Platelets 2004; 15: 439-46

    Ver abstract

  • Navarro-López F, Francino A, Serra A, Enjuto M, Reverter JC, Jimenez de Anta T, Betriu A [Late T-lymphocyte and monocyte activation in coronary restenosis. Evidence for a persistent inflammatory/immune mechanism?]. Rev Esp Cardiol 2003; 56: 465-72

    Ver abstract

Una iniciativa de

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar